Home » Newsletters » BioWorld Science

BioWorld Science

April 20, 1998

View Archived Issues

Hypoglycemic effects of the alpha2-adrenoceptor antagonists SL-84.0418 and deriglidole

T-794: a MAO-A inhibitor with antidepressant activity

Evaluation of combination therapy for the treatment of erectile dysfunction

Effects of aspirin + ticlopidine combination antiplatelet therapy following stent implantation

Genentech: Q1 1998 highlights

Idun seeks licensing partners for apoptosis regulators

Sertraline: a selective serotonin reuptake inhibitor for the treatment of PMDD

New endothelin antagonists from Bristol-Myers Squibb

Synthetic dolastatin derivatives as antitumor agents

Akorn acquires ophthalmic products from Alza

Company Profile: Ixion Biotechnology

Fujisawa-Fisons to promote respiratory product in Japan

Alza acquires Canadian rights to Ditropan

Schering-Plough seeks FDA approval for Intron A combination

COX-2 inhibitors claimed by AHP for arthritis, cancer and AD

Novel cell adhesion inhibitors discovered at Biogen

Chiesi prepares new anticonvulsants and neuroprotective agents

P&U claims new distamycin derivatives and their use as antitumor and antiviral agents

Conjugates for imaging vascular thrombi developed at NeoRx/U. of Washington

First launch for topical biologic that helps heal diabetic foot ulcers

Potential preventive HIV vaccine shows promise in preclinical studies

RPR's Gliadel Wafer approved in Argentina

Abbott acquires control of Murex, as previously agreed

Provid Research: new Praecis chemistry division

Cardiovascular gene therapy focus of Cell Genesys-Mitotix agreement

New data confirms efficacy of Zomig

SWR-0035: new beta3-adrenoceptor agonist introduced at Japanese meeting

Fujisawa develops compound with submicromolar activity against H. pylori

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...